Los costos de envío se calcularán en base a esta dirección en todo el sitio.
Selecciona tu país
América
Argentina
Brasil
Canadá
Chile
Colombia
Costa Rica
Ecuador
El Salvador
Estados Unidos
México
Perú
República Dominicana
Uruguay
Europa
Alemania
Austria
Bélgica
Croacia
Dinamarca
Eslovaquia
Eslovenia
España
Finlandia
Francia
Grecia
Hungría
Irlanda
Italia
Letonia
Malta
Noruega
Países Bajos
Polonia
Portugal
Reino Unido
República Checa
Serbia
Suecia
Suiza
Resto del mundo


Thriving with Spinocerebellar Ataxia (en Inglés)
Dr. Sarah Linton (Autor) · Dr. Sarah Linton · Tapa Blanda
Quedan más de 100 unidades
$ 57.607A progressive neurological disorder can begin with subtle changes in coordination, balance, speech, or eye movements before developing into a complex multisystem condition. Understanding its origins requires more than recognizing clinical symptoms. It requires an integrated view of genetics, molecular biology, cerebellar function, neurodegeneration, diagnostic reasoning, and long term care.
This guide provides a comprehensive examination of hereditary cerebellar disorders associated with progressive ataxia, connecting genetic abnormalities with the cellular mechanisms that drive neuronal dysfunction and clinical disease. It explores repeat expansion disorders, inheritance patterns, genotype phenotype relationships, selective neuronal vulnerability, protein toxicity, RNA mediated mechanisms, mitochondrial dysfunction, impaired proteostasis, and other processes involved in neurodegeneration.
Particular attention is given to clinical phenotyping and diagnostic evaluation, including neurological examination, neuroimaging, differential diagnosis, genetic testing, variant interpretation, and the challenges of distinguishing inherited ataxia from acquired and other degenerative conditions.
The discussion then moves into practical patient care, covering symptomatic management, rehabilitation, speech and swallowing support, functional assessment, multidisciplinary care, genetic counselling, family considerations, and long term follow up.
The guide also examines the rapidly developing therapeutic landscape. Antisense oligonucleotides, RNA interference, gene silencing, viral vector approaches, gene replacement, genome editing, proteostasis based strategies, mitochondrial interventions, biomarkers, and precision medicine are considered in the context of their scientific rationale and current stage of development. Emerging clinical trial designs and the challenges involved in translating promising molecular discoveries into safe and effective treatments are also explored.
Written for patients, advanced students, healthcare professionals, researchers, and informed readers, this volume provides a balanced perspective on a challenging group of neurological disorders while distinguishing established clinical practice from investigational approaches.
¿Tienes una pregunta sobre el libro? Inicia sesión para poder agregar tu propia pregunta.

